4,4,11b-trimethyl-7-oxo-2,3,4a,5,6,8,11,11a-octahydro-1H-cyclohepta[a]naphthalene-6a,9-dicarbaldehyde

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4,4,11b-trimethyl-7-oxo-2,3,4a,5,6,8,11,11a-octahydro-1H-cyclohepta[a]naphthalene-6a,9-dicarbaldehyde
• 化学式: C₂₀H₂₈O₃
• 分子量: 316.4
• InChiKey: ZTWLJQGQEGDQNJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  51.2
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR MODULATORS AND USES THEREOF IN REGULATING BLOOD GLUCOSE LEVELS
  申请人：Liang Chi-Ming

  公开号：US20140350100A1

  公开（公告）日：2014-11-27

  The present disclosure provides novel glucagon-like peptide-1 (GLP-1) receptor modulators such as compounds of Formula (I) or (II), and pharmaceutically acceptable salts thereof. The present disclosure also provides pharmaceutical compositions, kits, and uses that involve the GLP-1 receptor modulators for regulating blood glucose levels and/or treating diabetes via, e.g., modulating the endogenous signaling pathways mediated by the GLP-1 receptor.

  本公开提供了新型胰高血糖素样肽-1（GLP-1）受体调节剂，例如式（I）或（II）的化合物，以及其药学上可接受的盐。本公开还提供了涉及GLP-1受体调节剂用于调节血糖水平和/或治疗糖尿病的药物组合物、试剂盒和用途。例如，通过调节由GLP-1受体介导的内源性信号通路。
• SYNTHESIS OF GALANAL COMPOUNDS AND ANALOGUES THEREOF
  申请人：Academia Sinica

  公开号：US20140350288A1

  公开（公告）日：2014-11-27

  The present disclosure provides methods of preparing glucagon-like peptide-1 (GLP-1) receptor modulators, such as compounds of Formula (II) or (VI), or intermediates thereof. The compounds that may be prepared by the described methods are useful for regulating blood glucose levels and/or treating a disease mediated by a GLP-1 receptor (e.g., diabetes).
• US9193665B2
  申请人：——

  公开号：US9193665B2

  公开（公告）日：2015-11-24
• [EN] GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR MODULATORS AND USES THEREOF IN REGULATING BLOOD GLUCOSE LEVELS<br/>[FR] MODULATEURS DU RÉCEPTEUR DU GLUCAGON-LIKE PEPTIDE 1 (GLP-1) ET LEURS UTILISATIONS DANS LA RÉGULATION DES TAUX DE GLYCÉMIE
  申请人：ACADEMIA SINICA

  公开号：WO2014193832A2

  公开（公告）日：2014-12-04

  The present disclosure provides novel glucagon-like peptide-1 (GLP-1) receptor modulators such as compounds of Formula (I) or (II), and pharmaceutically acceptable salts thereof. The present disclosure also provides pharmaceutical compositions, kits, and uses that involve the GLP-1 receptor modulators for regulating blood glucose levels and/or treating diabetes via, e.g., modulating the endogenous signaling pathways mediated by the GLP-1 receptor.
• [EN] SYNTHESIS OF GALANAL COMPOUNDS AND ANALOGUES THEREOF<br/>[FR] SYNTHÈSE DE COMPOSÉS DE GALANAL ET LEURS ANALOGUES
  申请人：ACADEMIA SINICA

  公开号：WO2014193837A1

  公开（公告）日：2014-12-04

  The present disclosure provides methods of preparing glucagon-like peptide-1 (GLP-1) receptor modulators, such as compounds of Formula (II) or (VI), or intermediates thereof. The compounds that may be prepared by the described methods are useful for regulating blood glucose levels and/or treating a disease mediated by a GLP-1 receptor (e.g.diabetes).